| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 06/23/2011 | CA2781390A1 Bridged bicyclic rho kinase inhibitor compounds, composition and use |
| 06/23/2011 | CA2781228A1 Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri) |
| 06/23/2011 | CA2781186A1 New phenylhydrazone derivatives and their use as pharmaceuticals |
| 06/23/2011 | CA2780290A1 Mk2 inhibitors |
| 06/23/2011 | CA2780155A1 Ethynyl derivatives |
| 06/22/2011 | EP2336131A1 Hydantoin compounds |
| 06/22/2011 | EP2336130A1 Compound having substituted anthracene ring structure and pyridoindole ring structure and organic electroluminescence device |
| 06/22/2011 | EP2336129A1 1-aza-bicyclo[3.3.1]nonanes |
| 06/22/2011 | EP2336123A2 Heterocyclic compound as protein kinase inhibitor |
| 06/22/2011 | EP2335700A1 Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| 06/22/2011 | EP2334680A2 Hcv protease inhibitors |
| 06/22/2011 | EP2334679A1 Process for preparing varenicline, varenicline intermediates, and pharmaceutically acceptable salts thereof |
| 06/22/2011 | EP2334677A1 Triazolopyridine compounds as pim kinase inhibitors |
| 06/22/2011 | EP2334676A1 Substituted 3 -amin0- 1-0x0 or thioxo-i, 2,5,6,7, 8-hexahydr0-2, 7-naphthyridine-4-carb0nitriles as selective alpha 2b antagonists |
| 06/22/2011 | EP2334675A1 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors |
| 06/22/2011 | EP2334674A1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases. |
| 06/22/2011 | EP2334673A1 PYRIDO[3,2-d]PYRIDAZINE-2(1H)-ONE COMPOUNDS AS P38 MODULATORS AND METHODS OF USE THEREOF |
| 06/22/2011 | EP2334672A1 New compounds i |
| 06/22/2011 | EP2334179A1 Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia |
| 06/22/2011 | EP2231662B1 8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents |
| 06/22/2011 | EP2038356B8 Liquid hardening |
| 06/22/2011 | EP2013208B1 Pyridin[3,4-b]pyrazinones |
| 06/22/2011 | EP1994020B1 Substituted quinolones III |
| 06/22/2011 | EP1812004B1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 06/22/2011 | CN1942468B Process for production of pyrazole-fused ring derivatives |
| 06/22/2011 | CN1898244B Triazole derivatives as vasopressin antagonists |
| 06/22/2011 | CN1894246B Novel crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt |
| 06/22/2011 | CN102105473A Tricyclic nitrogen containing compounds and their use as antibacterials |
| 06/22/2011 | CN102105472A Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 06/22/2011 | CN102105471A Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 06/22/2011 | CN102105470A Anti-infective compounds |
| 06/22/2011 | CN102105467A Tricyclic alkylaminomethyloxazolidinone derivatives |
| 06/22/2011 | CN102105464A Wnt protein signalling inhibitors |
| 06/22/2011 | CN102105451A Glucokinase activators |
| 06/22/2011 | CN102105448A Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states |
| 06/22/2011 | CN102101868A 1,1'-bicarboline N,N'-dioxocompound and synthesis and application thereof |
| 06/22/2011 | CN102101861A Synthesis and process method of nitrogen-containing bis-heterocyclic medicine intermediate |
| 06/22/2011 | CN102101860A Novel method for synthesizing key intermediate of minodronate |
| 06/22/2011 | CN102101859A Quinolone carboxylic acid derivatives and application thereof |
| 06/22/2011 | CN101555248B Method for preparing poly-substituted 1, 5-naphthyridine compound |
| 06/22/2011 | CN101475571B Beta-carbolines cell cycle protein related kinase 2 inhibitor and use thereof |
| 06/22/2011 | CN101001857B 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 06/21/2011 | US7964728 Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition |
| 06/21/2011 | US7964608 Tricyclic compounds as modulators of TNF-α synthesis |
| 06/21/2011 | US7964600 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 06/21/2011 | US7964361 Rigidized trimethine cyanine dyes |
| 06/21/2011 | CA2635412C Agent for prophylaxis and treatment of asthenopia or pseudomyopia |
| 06/21/2011 | CA2507707C 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 06/21/2011 | CA2442114C N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 06/16/2011 | WO2011072241A1 4 -oxo- ih -quinoline- 3 - carboxamides as modulators of atp -binding cassette transporters |
| 06/16/2011 | WO2011071725A1 Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core |
| 06/16/2011 | WO2011071136A1 Therapeutic agent for fibromyalgia |
| 06/16/2011 | WO2011070299A1 Tri-substituted 9h-beta-carboline (or 9h-pyrido[3,4-b]indole) derivatives, preparation of same and therapeutic use thereof |
| 06/16/2011 | WO2011070298A1 Di-substituted 9h-pyrido[3,4-b]indole derivatives, preparation of same and therapeutic use thereof |
| 06/16/2011 | WO2011045561A3 Herbicidal compounds |
| 06/16/2011 | WO2011042107A3 Materials for organic electroluminescent devices |
| 06/16/2011 | WO2011021726A3 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation |
| 06/16/2011 | US20110144342 Process for the preparation of 7-ethyl-10-[4- (1-piperidino)- 1-piperidino] carbonyloxy-camptothecin hydrochloride trihydrate |
| 06/16/2011 | US20110144169 Inhibitors of cellular necrosis |
| 06/16/2011 | US20110144149 Gemifloxacin process and polymorphs |
| 06/16/2011 | US20110144146 Aminomethyl Substituted Bicyclic Aromatic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor |
| 06/16/2011 | US20110144138 Substituted pyrimido isoquinoline derivatives |
| 06/16/2011 | US20110144132 Substituted pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144121 Bicyclic pyrazolo-heterocycles |
| 06/16/2011 | US20110144105 Azaindole glucokinase activators |
| 06/16/2011 | US20110144100 Triazolopyridine compounds as pim kinase inhibitors |
| 06/16/2011 | US20110144099 Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 06/16/2011 | US20110144094 Heterocyclic tetracyclic tetrahydrofuran derivatives |
| 06/16/2011 | US20110144085 Triazolopyridine compounds as pim kinase inhibitors |
| 06/16/2011 | US20110144084 6 substituted 2- heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 06/16/2011 | US20110143942 Pyrazolyl-Substituted Heterocycles and Their Use as Phytosanitary Products |
| 06/16/2011 | US20110143925 Catalysts and methods for catalytic oxidation |
| 06/16/2011 | US20110143387 Highly water-soluble, cationic luminescent labels |
| 06/16/2011 | US20110142856 Compound containing basic group and use thereof |
| 06/16/2011 | US20110142826 Azaindolizines and methods of use |
| 06/16/2011 | US20110142796 Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inhibitors |
| 06/16/2011 | US20110142758 Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods |
| 06/16/2011 | US20110142717 Emissive sensors and devices incorporating these sensors |
| 06/16/2011 | US20110140092 Charge transport compositions and electronic devices made with such compositions |
| 06/16/2011 | US20110140043 Materials for organic electroluminescence device |
| 06/16/2011 | CA2783314A1 4-oxo-1h-quinoline-3-carboxamides as modulators of atp-binding cassette transporters |
| 06/15/2011 | EP2332940A1 Azaindoles useful as inhibitors of JAK and other protein kinases |
| 06/15/2011 | EP2332939A1 Novel Naphthyridine derivatives and the use thereof as kinase inhibitors |
| 06/15/2011 | EP2332938A1 Viral inhibitors |
| 06/15/2011 | EP2332935A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 06/15/2011 | EP2332923A1 5-ý2-(methylthio)ethoxy¨pyrimidine-2-amine manufacturing method |
| 06/15/2011 | EP2332918A1 Sulfonamide derivatives of polycyclic dyes for analytical applications |
| 06/15/2011 | EP2332909A1 Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 06/15/2011 | EP2332539A1 Pharmaceutical preparation, food or beverage having inhibitory activity on serotonin transporter |
| 06/15/2011 | EP2331543A1 3-deazaneplanocin derivatives |
| 06/15/2011 | EP2331541A1 Indolizine inhibitors of leukotriene production |
| 06/15/2011 | EP2331540A1 Berberine compounds and processes for the preparation of berberine compounds |
| 06/15/2011 | EP2331523A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
| 06/15/2011 | EP2331518A1 New bradykinin b1 antagonists |
| 06/15/2011 | EP2331502A2 Compounds for the treatment of hepatitis c |
| 06/15/2011 | EP2331500A1 Pyrrolidine n-benzyl derivatives |
| 06/15/2011 | EP2331101A1 Monocyclic amide cgrp receptor antagonists |
| 06/15/2011 | EP2331095A1 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 06/15/2011 | EP2330902A1 Chemical compounds |